AnaptysBio, Inc. - Common Stock — Bilan (NASDAQ:ANAB) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 416.55 M643.07 M610.38 M452.39 M483.83 M364.39 M Total du passif 19.82 M35.55 M43.87 M53.48 M59.54 M50.66 M Total des capitaux propres 396.73 M356.43 M262.1 M88.1 M70.87 M37.21 M Total du passif et des capitaux propres 416.55 M643.07 M610.38 M452.39 M483.83 M364.39 M Dette totale —————— Dette nette ——————

Nouvelles

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

AnaptysBio dévoile ses résultats en tant que société de redevances